159 related articles for article (PubMed ID: 35999136)
1. Knockdown of FGFR3 inhibits the proliferation, migration and invasion of intrahepatic cholangiocarcinoma.
Chen YH; Yang SH; Liu LX; Hu S; Wang XJ; Liao ZJ; Huan YF; He K; Zhang XW
Dig Liver Dis; 2023 Mar; 55(3):400-406. PubMed ID: 35999136
[TBL] [Abstract][Full Text] [Related]
2. Calcium-sensing receptor promotes tumor proliferation and migration in human intrahepatic cholangiocarcinoma by targeting ERK signaling pathway.
Fang Y; Liu L; Liu S; Hu L; Cai W; Wan X; Liu D; He Y; Zhu Z
Eur J Pharmacol; 2020 Apr; 872():172915. PubMed ID: 31926993
[TBL] [Abstract][Full Text] [Related]
3. Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway.
Zhang H; Dong X; Ding X; Liu G; Yang F; Song Q; Sun H; Chen G; Li S; Li Y; Wang M; Guo T; Zhang Z; Li B; Yang L
J Transl Med; 2023 Dec; 21(1):900. PubMed ID: 38082327
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of ROS-FIG inhibits cell proliferation, colony‑formation, cell cycle progression, migration and invasion, while inducing apoptosis in intrahepatic cholangiocarcinoma cells.
Deng G; Hu C; Zhu L; Huang F; Huang W; Xu H; Nie W
Int J Mol Med; 2014 Sep; 34(3):661-8. PubMed ID: 24968753
[TBL] [Abstract][Full Text] [Related]
5. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.
Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L
J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939
[TBL] [Abstract][Full Text] [Related]
6. Fascin Overexpression Promotes Cholangiocarcinoma RBE Cell Proliferation, Migration, and Invasion.
Zhao H; Yang F; Zhao W; Zhang C; Liu J
Technol Cancer Res Treat; 2016 Apr; 15(2):322-33. PubMed ID: 25882880
[TBL] [Abstract][Full Text] [Related]
7. Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro.
Wu WR; Zhang R; Shi XD; Zhu MS; Xu LB; Zeng H; Liu C
Oncol Rep; 2014 Jun; 31(6):2515-24. PubMed ID: 24700253
[TBL] [Abstract][Full Text] [Related]
8. MiR-376c down-regulation accelerates EGF-dependent migration by targeting GRB2 in the HuCCT1 human intrahepatic cholangiocarcinoma cell line.
Iwaki J; Kikuchi K; Mizuguchi Y; Kawahigashi Y; Yoshida H; Uchida E; Takizawa T
PLoS One; 2013; 8(7):e69496. PubMed ID: 23922722
[TBL] [Abstract][Full Text] [Related]
9. High expression of protein tyrosine kinase 7 significantly associates with invasiveness and poor prognosis in intrahepatic cholangiocarcinoma.
Jin J; Ryu HS; Lee KB; Jang JJ
PLoS One; 2014; 9(2):e90247. PubMed ID: 24587299
[TBL] [Abstract][Full Text] [Related]
10. NOV/CCN3 Promotes Cell Migration and Invasion in Intrahepatic Cholangiocarcinoma via miR-92a-3p.
Liang T; Shen L; Ji Y; Jia L; Dou Y; Guo L
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828265
[TBL] [Abstract][Full Text] [Related]
11. HSPB8 promoted intrahepatic cholangiocarcinoma progression by enhancing epithelial-mesenchymal transition and autophagy.
Shu B; Zhou Y; Liang Q; He C; Li F
Exp Mol Pathol; 2021 Dec; 123():104691. PubMed ID: 34606781
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
13. WAVE3 Induces EMT and Promotes Migration and Invasion in Intrahepatic Cholangiocarcinoma.
Zhu Z; Chen W; Yin X; Lai J; Wang Q; Liang L; Wang W; Wang A; Zheng C
Dig Dis Sci; 2016 Jul; 61(7):1950-60. PubMed ID: 26971088
[TBL] [Abstract][Full Text] [Related]
14. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR.
Li L; Zhang S; Li H; Chou H
BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201
[TBL] [Abstract][Full Text] [Related]
15. SATB1 is a potential therapeutic target in intrahepatic cholangiocarcinoma.
Zhao Z; Ma J; Wu K; Chen L; Yu J; Hu W; Zhang K
Clin Transl Oncol; 2016 Sep; 18(9):878-83. PubMed ID: 26563145
[TBL] [Abstract][Full Text] [Related]
16. Depletion of STYK1 inhibits intrahepatic cholangiocarcinoma development both in vitro and in vivo.
Chen MY; Zhang H; Jiang JX; Sun CY; Yu C; Tian S
Tumour Biol; 2016 Oct; 37(10):14173-14181. PubMed ID: 27542675
[TBL] [Abstract][Full Text] [Related]
17. Involvement of c-Met/hepatocyte growth factor pathway in cholangiocarcinoma cell invasion and its therapeutic inhibition with small interfering RNA specific for c-Met.
Leelawat K; Leelawat S; Tepaksorn P; Rattanasinganchan P; Leungchaweng A; Tohtong R; Sobhon P
J Surg Res; 2006 Nov; 136(1):78-84. PubMed ID: 16950403
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of Gab1 inhibits cell proliferation and migration in hilar cholangiocarcinoma.
Sang H; Li T; Li H; Liu J
PLoS One; 2013; 8(11):e81347. PubMed ID: 24312291
[TBL] [Abstract][Full Text] [Related]
19. miR-204 inhibits epithelial to mesenchymal transition by targeting slug in intrahepatic cholangiocarcinoma cells.
Qiu YH; Wei YP; Shen NJ; Wang ZC; Kan T; Yu WL; Yi B; Zhang YJ
Cell Physiol Biochem; 2013; 32(5):1331-41. PubMed ID: 24280681
[TBL] [Abstract][Full Text] [Related]
20. Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines.
Yang J; Sontag D; Gong Y; Minuk GY
Ann Hepatol; 2021; 21():100265. PubMed ID: 33045415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
